Close X
Attorney Spotlight

How did Mike DeAgro's experience co-founding a nonprofit advocacy organization lead to a career in the legal field? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Best Practices for Responding to Patent Demand Letters

Events

February 16, 2018

Bass, Berry & Sims attorney Brian Iverson is presenting a Clear Law Institute webinar titled, "Best Practices for Responding to Patent Demand Letters." This 75-minute program will offer practical guidance on effectively evaluating and responding to patent demand letters. The webinar will cover:

  • Various types of patent demand letters
  • Key factors for strategically analyzing a patent demand letter
  • Special considerations for dealing with non-practicing entities
  • Laws protecting demand letter recipients
  • Options for responding to a patent demand letter
  • Potential legal developments on the horizon that might influence your response strategy
  • What you should and should not say in a response letter

The webinar will be held on Friday, February 16 from 1:00 p.m. – 2:15 p.m. EST. This program is eligible for 1.25 Tennessee CLE Credit Hours. For more information and registration, visit the Clear Law Institute website.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.